NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs041190107

Registered date:20/01/2020

Measurement of NAD+ metabolites in blood after oral intake of Vitamin B3

Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiedN/A
Date of first enrollment24/01/2020
Target sample size6
Countries of recruitment
Study typeInterventional
Intervention(s)1st: Meassure levels of Nicotinamide and NAD+ metabolites after oral supplementation of 100 mg Nicotinamide Powder 10% Zonne 2nd: Meassure levels of Nicotinamide and NAD+ metabolites after oral supplementation of 500 mg Nicotinamide Powder 10% Zonne

Outcome(s)

Primary OutcomePharmacokinetics of NAD+ as the changed form of supplemented nicotinamide
Secondary OutcomePharmacokinetics of nicotinamide Safety assessment mainly for liver functions

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximum<= 80age old
GenderBoth
Include criteria1. Healthy adults between ages of 20 years old and 80 years old 2. Those who gaven written consent to study
Exclude criteria1. Current use of medications and supplements including Vitamin B3 2. Pregnancy 3. Lactation 4. Current use of medications 5. Any other conditions medical doctors find inadequate to participate in study

Related Information

Contact

Public contact
Name Takashi Ito
Address 2-1,Hirosawa,Wako,Saitama Saitama Japan 351-0198
Telephone +81-48-467-9516
E-mail itotakakun77777@gmail.com
Affiliation RIKEN
Scientific contact
Name Tomohito Sato
Address 1-20-1,Handayama,Higashiku,Hamamatsu,Shizuoka Shizuoka Japan 431-3192
Telephone +81-53-435-2111
E-mail titon0620@gmail.com
Affiliation Hamamatsu University Hospital